The US Food and Drug Administration (FDA) has approved a new, once-daily oral stimulant medication for treatment of attention deficit
Continue reading »
mypharmacynews.com
The US Food and Drug Administration (FDA) has approved a new, once-daily oral stimulant medication for treatment of attention deficit
Continue reading »NEW YORK (Reuters Health) – Peanut allergy has dropped in Australia after children began to be introduced to peanuts early
Continue reading »NEW YORK (Reuters Health) – Although cumulative dose is important, how cisplatin is administered to young patients with cancer also
Continue reading »(Reuters Health) – Infants with neonatal opioid withdrawal syndrome (NOWS) may have shorter hospital stays and spend less time on
Continue reading »The US Food and Drug Administration (FDA) has cleared a new over-the-counter device designed to protect children aged 13 years
Continue reading »The Biden administration nominees for surgeon general and assistant secretary for health had a mostly positive reception from senators during
Continue reading »A JAMA journal is retracting and replacing a 2020 paper which linked exposure to nonionizing radiation — think cellphones, Bluetooth
Continue reading »(Reuters Health) – Children with Hirschsprung disease may be at increased risk for developing inflammatory bowel disease, a Canadian study
Continue reading »A new computational analysis suggests that people under the age of 20 are about half as susceptible to COVID-19 infection
Continue reading »Parents now have an extra reason to say no to candy, cake and ice cream for young children. The first
Continue reading »